Vorapaxar’s benefits exceed risks in select patients only Clinical study 12 January 2013 Pages: 1 - 1
Citalopram label recognises need for use in some at-risk patients News item 12 January 2013 Pages: 2 - 2
The American Geriatrics Society (AGS) has announced the publication of a new version of the Beers Criteria, Media release 12 January 2013 Pages: 3 - 3
The Australian TGA has launched a database for prescribing medicines in pregnancy, News item 12 January 2013 Pages: 3 - 3
Bristol-Myers Squibb (BMS) has issued new risk minimisation advice regarding the use of Perfalgan [IV paracetamol] in neonates and infants, News item 12 January 2013 Pages: 3 - 3
Use of saxagliptin [Onglyza] is now contraindicated in patients with a history of serious hypersensitivity reaction to any DPP-4 inhibitor, News item 12 January 2013 Pages: 3 - 3
Administration of Benlysta [belimumab] may result in severe or life-threatening hypersensitivity and infusion reactions, News item 12 January 2013 Pages: 3 - 3
Chorionic gonadotropin/recombinant follicle stimulating hormone Case report 12 January 2013 Pages: 15 - 15